Navigation Links
Sanofi US and Joslin Diabetes Center Announce Results from Multicultural Outreach Pilot at American Diabetes Association Scientific Sessions
Date:6/22/2013

essages and, if they have elevated A1C and blood pressure results, show similar improvement in biomarker outcomes as those participants who were diagnosed with diabetes prior to participating in the Program.  

The On the Road pilot also demonstrates that community members with little or no prior healthcare delivery experience can be trained to deliver simple, standardized messaging to their communities, resulting in improved participant health outcomes. This success implies scalability of a low-cost intervention for multicultural and underserved populations. 

"We are encouraged by the results of this multicultural pilot," stated Dennis Urbaniak, Vice President and Head of U.S. Diabetes Patient Centered Unit, Sanofi US.  "And, we are looking forward to our continued partnership with Joslin and our combined efforts to help people living with diabetes, especially those in underserved populations."

About the Study
The pilot was conducted in four ethnically diverse cities over three months reaching 369 participants. The objectives were to reach underserved populations, engage them in the healthcare system, increase awareness of key diabetes tests, and measure changes in biomarkers and healthy behaviors. The intervention included a 1-hour baseline class on understanding key diabetes tests plus collection of data (surveys, blood pressure (BP), and point-of-care A1C). The 3-month follow-up class included re-collection of data and a 1-hour class on healthy eating.

Four community liaisons (CLs) (individuals familiar with the target communities but not previously trained in health education) recruited participants and delivered the program.  The CLs completed two 4-hour training sessions on program delivery and were supported with periodic team phone calls.  Baseline data revealed the target population was reached (60% with annual household income <$25,000, 45% w
'/>"/>

SOURCE Sanofi
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Sanofi Pasteur Presents Pediatric Data on Investigational Quadrivalent Influenza Vaccine
2. Sanofi US Launches Collaborate Activate Innovation Challenge
3. Sanofi Pasteur to add 2D barcode to six more vaccines
4. Sanofi and Regeneron Announce Publication of Phase 2 Results with LDL Cholesterol-Lowering PCSK9 Antibody in the New England Journal of Medicine
5. Sanofi and Regeneron Announce Patient Enrollment in Cardiovascular Outcomes Trial with Antibody to PCSK9 for Hypercholesterolemia
6. Sanofi and T1D Exchange to Launch Worldwide Study to Investigate Factors for Optimal Care for Young People with Diabetes
7. Sanofi Donates $500,000 to Hurricane Sandy for Immediate and Long-Term Relief Efforts
8. Phase II Trial of Sanofi JAK2 Inhibitor in Myelofibrosis Met Primary Endpoint
9. Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
10. Zacks Bull and Bear of the Day Highlights: Smithfield Foods, Logitech International, Sanofi, Isis Pharmaceuticals and Aegerion Pharmaceuticals
11. Sanofi New Drug Application for Lixisenatide Accepted for Review by FDA
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)...  Alimera Sciences, Inc. (NASDAQ: ALIM ) ... development and commercialization of prescription ophthalmic pharmaceuticals, today announced ... year 2014 financial results after the market close on ... follow on the same day at 4:30 p.m. ET. ... by Dan Myers , President and Chief Executive ...
(Date:7/24/2014)... , July 24, 2014  The American ... is supporting its mission to help address audit ... and exclusive agreement to be the information technology ... As the leading provider of billing and business ... unmatched HME industry expertise to support this important ...
(Date:7/24/2014)... , July 24, 2014  In any given hospital ... 25 patients has at least one hospital-acquired infection, according ... more, many of these infections prove fatal. And as ... alarming number of patient deaths per year, infection control ... Consequently, a stronger emphasis is being ...
Breaking Medicine Technology:Alimera Sciences To Release Second Quarter 2014 Results 2Brightree Joins AAHomecare as Corporate Partner and IT Lead on HME Audit Key 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 2Employees, Equipment and the Environment: Top Infection Prevention Focuses in Hospitals 3
... Computer Company (PCC) – a Vermont pediatric software developer ... updated 5010 transaction standard for electronic claims and claims ... among its payers. An ICD-10/5010 Readiness Survey ... Systems Society (HIMSS), indicates an estimated 1/3 of health ...
... Masimo (NASDAQ: MASI ) announced today that it ... 2, 2011, after the market closes on May 3, 2011. ... 1:30 p.m. PT (4:30 p.m. ET) and will be hosted by ... Raad, Executive Vice President and Chief Financial Officer. A ...
Cached Medicine Technology:PCC Frustrated with Payers' Lack of 5010 Readiness 2Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011 2Masimo to Report First Quarter 2011 Financial Results After Market Close on May 3, 2011 3
(Date:7/25/2014)... Washington, DC (PRWEB) July 25, 2014 ... against some health plans for providing inadequate access to ... serious threats to the health and safety of beneficiaries ... of drug coverage determinations, and CMS is taking quick ... 5, the Atlantic Information Services webinar, “Avoiding Costly ...
(Date:7/25/2014)... iTanSmart is a patented iOS suntan ... provides a tailored approach to eliminating the guesswork from ... skin damage. In his review, Eaton had positive things ... iTanSmart. , Eaton begins his commentary ... organized’ and ‘great alternative’ to its related Android competitor. ...
(Date:7/25/2014)... As the category creator and world leader in healthy ... transform and improve individual lives worldwide through its exclusive and ... a successful Austin, Texas based "Xocai Activ Drink" author, is ... July to promote the up and coming mxicorp.com/company/igc Eric Worre ... has been a leader in the Network Marketing Profession for ...
(Date:7/24/2014)... iFitDress.com, a renowned wedding dress manufacturer ... casual party dresses . According to the company’s ... now offered at discounted prices, up to 59% off. ... August 04. , Most of the casual party ... market. They are popular for special designs, delicate craftsmanship ...
(Date:7/24/2014)... For rats bearing human breast tumors, exposure to ... the breast cancer drug tamoxifen, according to data published ... American Association for Cancer Research. The negative effects of ... giving rats a melatonin supplement during the night. , ... with hormone receptor-positive breast cancer," said Steven M. Hill, ...
Breaking Medicine News(10 mins):Health News:Aug. 5 Webinar to Offer Strategies for Preventing Rx Access Issues and Avoiding Part D Sanctions 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 2Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 3Health News:Austin, Texas Based "Xocai Activ Drink" Author, Adam Paul Green, to Visit Niigata Japan to Promote mxicorp.com/company/igc Eric Worre Speaking Engagement 4Health News:2014 Casual Party Dresses for Chic Ladies Now at iFitDress.com 2Health News:Exposure to dim light at night may make breast cancers resistant to tamoxifen 2
... new analysis, it is better to give radiation therapy before ... well as surgery can reduce the risk of recurrence. Generally ... In Scandinavia and the Netherlands, the therapy is given before ... until afterwards.// ,An analysis of 8000 patients, led ...
... The diagnosis and treatment of epilepsy is often handled ... per cent of UK epilepsy patients not receiving appropriate ... epilepsy each year, and of these, about one-third can ... from the Institute of Neurology at University College London ...
... temperatures can lead to heat exhaustion and eventually to ... the temperature rises into the thirties. By the time ... ,Heat exhaustion refers to overheating of the ... rare cases, salt depletion. People who suffer from heat ...
... by cancer patients undergoing high-dose chemotherapy could be eased ... drugs used to fight cancer can prove extremely debilitating ... various anti-emetic drugs to lessen the reaction, but in ... a possible extra help. ,Acupuncture involves the insertion of ...
... Patients' experience of illness is being collected on a database ... ingredient in medical research is the patient's voice. It is ... researchers could learn a lot from the patient's ideas, beliefs ... too - showing they're not alone, and giving them vital ...
... able to treat the neurological problems that are common ... suffer from kidney failure, which is usually caused by ... leads to neurological complications like fatigue, apathy, emotional instability ... at the University of California at Irvine have learned ...
Cached Medicine News:
... The Bledsoe Lever Lock Knee Brace ... extension lock of the arthroscopic ACL ... allow motion for rehabilitation or passive ... locked "rigidly" in full extension for ...
The Bledsoe Basic Knee Brace offers a broad range of features that are unmatched by any other brace in its price range. Application of this brace is the easiest of any brace on the market....
... Bird and Cronin, ... manufacturer of Patient Footwear, ... Patient Care Products. Our ... highest quality and available ...
SofTec Genu is the first functional brace that provides full soft tissue control, enhances natural muscle movement, prevents atrophy, increases proprioception and controls A/P laxity....
Medicine Products: